Skip to content
Home/Companies/Biotech/Guard Therapeutics

Guard Therapeutics

Biotech·Sweden·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Guard Therapeutics?

Guard Therapeutics is a Swedish Biotech company, currently owned by Industrifonden since 2022.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
Industrifonden
Investor
Industrifonden
Industrifonden Evergreen · 1991 · VC

Key facts

HQSweden
SectorBiotech
StatusActive

More from Industrifonden Evergreen

Other portfolio companies in the same fund.

Agteria Biotech
Active
AgTechSweden· 2025
Echandia
Active
ClimateTechSweden· 2025
Tribune Therapeutics
Active
BiotechSweden· 2025
Adamant Quanta
Active
Deep TechSweden· 2023
AlixLabs
Active
Deep TechSweden· 2023
HVR Cardio
Active
MedTechSweden· 2023

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Guard Therapeutics?

Guard Therapeutics is currently owned by Industrifonden, through Industrifonden Evergreen, since 2022.

When did Industrifonden acquire Guard Therapeutics?

Industrifonden acquired Guard Therapeutics in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue